Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbonlife ATP in Chronic Wounds
NCT07223892Phase 3Not yet recruiting
- Start
- Jan 2026
- Primary completion
- Jan 2028
01
Overview
Phase 3, randomised, open-label trial in Chronic wound (2 arms). Primary endpoint: Wound Closure at 12 weeks. Planned start Jan 2026; status: not yet recruiting.
02
Conditions
Chronic wound
Beyond the preview
Go deeper on NCT07223892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07223892.